Literature DB >> 15698549

Phosphorylation of p70s6 kinase is implicated in androgen-induced levator ani muscle anabolism in castrated rats.

Tianshun Xu1, Ying Shen, Heather Pink, Jim Triantafillou, Stephen A Stimpson, Philip Turnbull, Bajin Han.   

Abstract

Androgens are known to increase muscle mass, strength and muscle protein synthesis. However, the molecular mechanisms by which androgens regulate skeletal muscle development remain poorly understood. The ribosomal protein kinase p70(s6k) is a regulator of ribosome biogenesis and plays an important role in the regulation of growth-related protein synthesis. The phosphorylation of p70(s6k) has been implicated in load-induced skeletal muscle hypertrophy. In the current study, we determined the effect of DHT on the phosphorylation of p70(s6k) in the androgen-sensitive levator ani muscle of castrated rats. DHT induced a rapid increase in the phosphorylation of p70(s6k), which was detectable within 6 h after a single injection. Interestingly, DHT-induced phosphorylation of p70(s6k) occurred only in androgen-sensitive muscles, but not prostate and seminal vesicle. Co-administration of flutamide, an AR antagonist, inhibited DHT-induced p70(s6k) phosphorylation. While serum IGF-I levels were not changed by DHT treatment, IGF-I gene expression levels increased and the mRNA levels of IGFBP3 and IGFBP5 were suppressed in the LA muscle after DHT replacement in castrated rats. These results suggest that the phosphorylation of p70(s6k), likely via the IGF-I pathway, may play an important role in androgen-induced skeletal muscle hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15698549     DOI: 10.1016/j.jsbmb.2004.07.008

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  8 in total

Review 1.  Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actions.

Authors:  Vanessa Dubois; Michaël Laurent; Steven Boonen; Dirk Vanderschueren; Frank Claessens
Journal:  Cell Mol Life Sci       Date:  2011-11-19       Impact factor: 9.261

2.  Nandrolone normalizes determinants of muscle mass and fiber type after spinal cord injury.

Authors:  Yong Wu; Jingbo Zhao; Weidong Zhao; Jiangping Pan; William A Bauman; Christopher P Cardozo
Journal:  J Neurotrauma       Date:  2012-04-16       Impact factor: 5.269

3.  Androgenic and estrogenic regulation of Atrogin-1, MuRF1 and myostatin expression in different muscle types of male mice.

Authors:  H De Naeyer; S Lamon; A P Russell; I Everaert; A De Spaey; B Vanheel; Y Taes; W Derave
Journal:  Eur J Appl Physiol       Date:  2014-01-05       Impact factor: 3.078

4.  Regulation of signaling pathways downstream of IGF-I/insulin by androgen in skeletal muscle of glucocorticoid-treated rats.

Authors:  Hui-Nan Yin; Jia-Ke Chai; Yong-Ming Yu; Chuan-An Shen; Yan-Qiu Wu; Yong-Ming Yao; Hui Liu; Li-Ming Liang; Ronald G Tompkins; Zhi-Yong Sheng
Journal:  J Trauma       Date:  2009-04

5.  Differential alterations in gene expression profiles contribute to time-dependent effects of nandrolone to prevent denervation atrophy.

Authors:  Weiping Qin; Jiangping Pan; William A Bauman; Christopher P Cardozo
Journal:  BMC Genomics       Date:  2010-10-22       Impact factor: 3.969

Review 6.  Activity-Based Physical Rehabilitation with Adjuvant Testosterone to Promote Neuromuscular Recovery after Spinal Cord Injury.

Authors:  Dana M Otzel; Jimmy Lee; Fan Ye; Stephen E Borst; Joshua F Yarrow
Journal:  Int J Mol Sci       Date:  2018-06-07       Impact factor: 5.923

7.  Androgen interacts with exercise through the mTOR pathway to induce skeletal muscle hypertrophy.

Authors:  Fanxing Zeng; Hua Zhao; Jingwen Liao
Journal:  Biol Sport       Date:  2017-09-20       Impact factor: 2.806

Review 8.  Selective androgen receptor modulator, S42 has anabolic and anti-catabolic effects on cultured myotubes.

Authors:  Yoshimi Muta; Tomoko Tanaka; Yuriko Hamaguchi; Nobuya Hamanoue; Ryoko Motonaga; Makito Tanabe; Takashi Nomiyama; Hajime Nawata; Toshihiko Yanase
Journal:  Biochem Biophys Rep       Date:  2019-01-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.